On January 9, 2025, Missouri lawmakers introduced House Bill 97, a significant piece of legislation aimed at enhancing public safety regarding allergic reactions, particularly those caused by food allergies. The bill seeks to establish comprehensive protocols for the administration of epinephrine auto-injectors, which are critical in treating severe allergic reactions.

One of the bill's key provisions is the establishment of immunity from liability for various stakeholders involved in the administration of epinephrine auto-injectors. This includes authorized entities, their employees, and individuals who use the auto-injectors in good faith. The legislation specifies that this immunity does not extend to actions demonstrating reckless disregard for safety, thereby balancing protection for those acting in emergency situations with accountability for negligent behavior.

Additionally, the bill mandates that all basic life support ambulances and stretcher vans in Missouri be equipped with epinephrine auto-injectors and staffed by trained personnel. This requirement aims to ensure that emergency responders are prepared to handle allergic reactions promptly, potentially saving lives.

House Bill 97 also requires licensed child care providers to adopt allergy prevention and response policies by July 1, 2027. These policies must address various levels of allergy management, from building-wide strategies to individual responses, emphasizing the importance of education and preparedness in environments frequented by children.

The introduction of this bill has sparked discussions among lawmakers and stakeholders about its implications. Proponents argue that it will significantly improve the safety of individuals with severe allergies, particularly children, while critics express concerns about the adequacy of training for those administering the auto-injectors and the potential for misuse.

As the legislative process unfolds, experts suggest that the bill could set a precedent for similar measures in other states, reflecting a growing recognition of the need for robust allergy management protocols. The outcome of House Bill 97 may not only impact public health policy in Missouri but could also influence national standards for allergy response in educational and emergency settings.